AOD-9604 is the C-terminal fragment of human GH (hGH 176-191) studied for adipogenesis regulation, lipolysis stimulation, and metabolic pathway research without the growth-promoting effects of full GH.
| Molecular Weight | 1817.1 g/mol |
| Purity | >98% |
| Form | Lyophilized powder |
| Storage | -20°C |
Science-backed research overview for this compound
AOD-9604 (Anti-Obesity Drug) is a synthetic peptide fragment derived from the C-terminus of human Growth Hormone (residues 176–191). It was specifically designed to capture the fat-burning power of HGH without its effects on blood sugar or cell growth.
AOD-9604 stimulates lipolysis (the breakdown of fat) and inhibits lipogenesis (the formation of new fat). Research indicates it works by mimicking the way natural GH regulates fat metabolism, but because it lacks the rest of the GH molecule, it does not increase IGF-1 or cause insulin resistance.
Clinical research has shown that AOD-9604 targets stubborn white adipose tissue specifically. It is also being studied for its regenerative potential in bone and cartilage repair, making it a unique dual-purpose research compound for both metabolic and structural health.